ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Clinical significance of histopathological features of paired recurrent gliomas: a cohort study from a single cancer center

Li, Cong; Xi, Shaoyan; Chen, Yingshen; Guo, Chengcheng; Zhang, Ji; Yang, Qunying; Wang, Jian; Sai, Ke; Zeng, Jing; Wang, Jing; Zhang, Zhiqiang; Ke, Chao; Chen, Zhongping*广东省人民医院; 广州中医药大学; 中山大学
BMC CANCER2023-1-3DOI: 10.1186/s12885-022-10484-9
1被引12阅读
引用收藏
分享

摘要

Objective: To explore the histopathological characteristics of paired recurrent gliomas and their clinical significance.Methods: Glioma patients who received both primary surgery and reoperation when recurrence at Sun Yat-sen University Cancer Center from June 2001 to June 2019 were enrolled. Clinical and pathological characteristics were analyzed retrospectively, and histopathology of reoperation specimens was divided into three categories according to tumor cell activity and the degree of necrosis: active group, low-activity group, and necrosis group.Results: A total of 89 patients were included in this study. The 2016 WHO grade of the first operation pathology and IDH1 status were related to survival time after the first operation, but there was no significant association with survival time after reoperation. The time interval between primary and reoperation was shorter for primary high-grade glioma and/or IDH1 wild-type tumor patients than for low-grade glioma and/or IDH1 mutant tumor patients (P < 0.001). Histopathological types of recurrent gliomas were analyzed, and 67 cases (75.3%) were classified into the active group, 14 (15.8%) into the low-activity group, and 8 (8.9%) into the necrosis group. The low-activity or necrosis group was associated with a higher radiotherapy dose and shorter operation interval. Further univariate and multivariate Cox survival analyses showed the histopathological patterns of recurrent gliomas to be related to survival time after reoperation.Conclusion: Primary WHO low grade or IDH1 mutant gliomas appeared survival benefit mainly on later recurrence, but was not a prognostic predictor following recurrence. Histopathological feature of recurrent glioma is related to previous treatment, including radiotherapy dosage and chemotherapy treatment, and is also an important independent prognostic factor for patients after reoperation.

学科与关键词

关键词
Recurrent gliomaReoperationHistopathologyPrognosis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
BMC CANCER
发表日期
2023-01-03
卷期
第 23 卷, 第 1 期
DOI
10.1186/s12885-022-10484-9
语言
ENGLISH
成果收录
SCIE

作者

  • L

    Li, Cong (第一作者)

    sun yat sen univ · 2 · guangdong prov hosp · guangzhou univ chinese med

  • X

    Xi, Shaoyan

    sun yat sen univ

查看全部 13 位作者收起作者
  • C

    Chen, Yingshen

    sun yat sen univ

  • G

    Guo, Chengcheng

    sun yat sen univ

  • Z

    Zhang, Ji

    sun yat sen univ

  • Y

    Yang, Qunying

    sun yat sen univ

  • W

    Wang, Jian

  • S

    Sai, Ke

    sun yat sen univ

  • Z

    Zeng, Jing

    sun yat sen univ

  • W

    Wang, Jing

  • Z

    Zhang, Zhiqiang

    2 · guangdong prov hosp · guangzhou univ chinese med

  • K

    Ke, Chao

    sun yat sen univ

  • C

    Chen, Zhongping (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417